Overview
56-Day Study in Participants with mild-to-moderate joint discomfort
This second randomized, double-blind, placebo-controlled study explored how a 250mg dose of patented TamaFlex affected subjects with induced joint discomfort.
This 56-day study with 81 participants demonstrated substantial reductions in joint discomfort, stiffness, and inflammation markers in the TamaFlex group. The trial underscored the product's efficacy in improving joint function and protecting cartilage.
Length of Study:
56 days
Study Size:
81 healthy adults
Average Age:
57 years
Dose:
250mg TamaFlex daily
Rapid and sustained joint health benefits
By day 5, the TamaFlex group started showing physical improvements:
Improvement in comfort
Improvement in stiffness
Improvement in physical activity
Improvement in a six-minute walk test
Improvement in a stair-climbing test
Improvement in the articulation of the knee joint
More TamaFlex Studies
More TamaFlex Clinical Studies
Explore our other clinical studies to see how TamaFlex consistently delivers remarkable improvements in joint health.
More TamaFlex Studies
More TamaFlex Clinical Studies
Explore our other clinical studies to see how TamaFlex consistently delivers remarkable improvements in joint health.
References:
Prasad N., Vinay V., and Srivastava A. Efficacy of a Proprietary Combination of Tamarindus indica Seeds and Curcuma longa Rhizome Extracts in Osteoarthritis: A Clinical Investigation. Food & Nutrition Research, vol. 67, 2023 June 20, doi: 10.29219/fnr.v67.9268.
Take Your Brand to the NXT Level with TamaFlex!
Contact Us to Explore TamaFlex’s Benefits!


